Literature DB >> 11600220

Antigen, allele, and haplotype frequencies report of the ASHI minority antigens workshops: part 1, African-Americans.

A A Zachary1, W B Bias, A Johnson, S M Rose, M S Leffell.   

Abstract

HLA typing was performed on 977 African Americans residing throughout most of the United States. Class I and class II antigens and class II alleles were defined for all individuals and class I alleles were determined for a subset of individuals. The occurrence of 854 of the individuals in family groups permitted direct counting of allele and haplotype frequencies. The data were analyzed for antigen, allele, and haplotype frequencies; recombination frequencies; segregation distortion; distribution of haplotype frequencies; linkage disequilibria; and geographic distribution of DR antigens. Tables of the antigen, allele, the most common two and three point haplotypes, and 88 extended haplotypes that include class I and class II alleles are presented. Notable findings include a lower than expected frequency of recombination between the B and DR loci (theta= 0.0013), lower than expected frequency of inheritance (44.5% vs 54.5%) of the DRB1*1503; DQB1*0602 haplotype, lower than anticipated linkage disequilibrium values for DR; DQ haplotypes, and a skewed geographic distribution of DR antigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600220     DOI: 10.1016/s0198-8859(01)00305-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations.

Authors:  Christopher L Bowlus; Chin-Shang Li; Tom H Karlsen; Benedicte A Lie; Carlo Selmi
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

Review 2.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 3.  Immunogenetics and immunology in transplantation.

Authors:  Andrea A Zachary; Dessislava Kopchaliiska; Annette M Jackson; Mary S Leffell
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

4.  A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.

Authors:  Marcus O Butler; Sascha Ansén; Makito Tanaka; Osamu Imataki; Alla Berezovskaya; Mary M Mooney; Genita Metzler; Matthew I Milstein; Lee M Nadler; Naoto Hirano
Journal:  Int Immunol       Date:  2010-11-08       Impact factor: 4.823

5.  HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Authors:  E K K Henriksen; M K Viken; M Wittig; K Holm; T Folseraas; S Mucha; E Melum; J R Hov; K N Lazaridis; B D Juran; O Chazouillères; M Färkkilä; D N Gotthardt; P Invernizzi; M Carbone; G M Hirschfield; S M Rushbrook; E Goode; C Y Ponsioen; R K Weersma; B Eksteen; K K Yimam; S C Gordon; D Goldberg; L Yu; C L Bowlus; A Franke; B A Lie; T H Karlsen
Journal:  HLA       Date:  2017-07-11       Impact factor: 4.513

6.  Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis.

Authors:  Johannes R Hov; Vasilis Kosmoliaptsis; James A Traherne; Marita Olsson; Kirsten M Boberg; Annika Bergquist; Erik Schrumpf; J Andrew Bradley; Craig J Taylor; Benedicte A Lie; John Trowsdale; Tom H Karlsen
Journal:  Hepatology       Date:  2011-05-13       Impact factor: 17.425

7.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

8.  Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.

Authors:  Sigrid Næss; Benedicte A Lie; Espen Melum; Marita Olsson; Johannes R Hov; Peter J P Croucher; Jochen Hampe; Erik Thorsby; Annika Bergquist; James A Traherne; Erik Schrumpf; Kirsten Muri Boberg; Stefan Schreiber; Andre Franke; Tom H Karlsen
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.